GILD Gilead Sciences
$166.43 -0.06%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-0.06%
YTD
+35.60%
P/E
24.51
P/B
6.71
ROE
-21.8%
Div yield
4.0%
Beta
0.36
Market cap
$208.6B
RSI (14)
54
Next earnings
Feb 8, 2027
Same sector · Health Care
Compare GILD with NVO and JNJ →Follow GILD in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$168.28
Close
$166.43
Day high
$170.24
Day low
$165.80
Volume
7.6M
Latest headlines
HIV Clinical Trials - Global Strategic Business Report 2026-2032 Featuring Strategic Intelligence on Gilead, ViiV Healthcare, Merck, and Pfizer
Yahoo Finance · Nov 20
How Investors Are Reacting To Gilead Sciences (GILD) HIV Prevention Expansion
Yahoo Finance · Nov 19
Where Could Gilead's Next Growth Come From?
Yahoo Finance · Nov 19
How Many Shares of Bristol Myers Squibb, Merck or Gilead Sciences Pay $1,000 a Month in Dividends?
Yahoo Finance · Nov 18
Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
Yahoo Finance · Nov 18
iShares Biotechnology ETF (IBB) Buys $16.2 Million More Gilead on Nov. 16
Yahoo Finance · Nov 18
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Oct 30, 2026 View → 8-K Oct 29, 2026 View → 10-Q Aug 6, 2026 View → 8-K Aug 4, 2026 View → 8-K May 20, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell GILD. Try it in the Lab to size a position and see the risk.